[PLX] QoQ Quarter Result on 31-Dec-2011 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
27-Feb-2012
Financial Year
2011
Quarter
31-Dec-2011 [#Q4]
Profit Trend
QoQ- -0.43%
YoY- -4.51%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 5,390 26,113 3,728 2,362 1,132 764 6,000 -6.87%
PBT -5,479 22 0 968 0 179 -5,052 5.54%
Tax -81 -8,765 -161 -27,616 108 20,699 0 -
NP -5,479 9,642 -5,904 -8,913 -8,875 -13,689 -5,052 5.54%
Tax Rate - 39,840.91% - 2,852.89% - -11,563.69% - -
Total Cost 10,869 16,471 9,632 11,275 10,007 14,453 11,052 -1.10%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin -101.65 36.92 -158.37 -377.35 -784.01 -1,791.75 -84.20 13.33%
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
EPS -0.06 0.11 -0.07 -1.01 -0.10 -0.16 -0.06 0.00%
EPS Diluted -0.06 0.10 -0.07 -1.01 -0.10 -0.16 -0.06 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.